Pacrinolol
Pacrinolol is a non-selective beta blocker medication that is primarily used to treat high blood pressure (hypertension) and certain heart conditions. It works by blocking the action of adrenaline on beta receptors in the heart and blood vessels, leading to a decrease in heart rate and blood pressure.
Mechanism of Action[edit | edit source]
Pacrinolol acts by competitively blocking beta-1 and beta-2 adrenergic receptors. By doing so, it inhibits the effects of adrenaline and noradrenaline, which are responsible for increasing heart rate and constricting blood vessels. This results in a reduction in heart rate, cardiac output, and blood pressure.
Indications[edit | edit source]
Pacrinolol is indicated for the treatment of:
- Hypertension
- Angina pectoris
- Arrhythmias
- Myocardial infarction
- Heart failure
Dosage and Administration[edit | edit source]
The dosage of pacrinolol may vary depending on the condition being treated and the individual patient's response. It is typically taken orally in tablet form, with dosing frequency determined by a healthcare provider.
Side Effects[edit | edit source]
Common side effects of pacrinolol may include:
- Fatigue
- Dizziness
- Bradycardia (slow heart rate)
- Hypotension (low blood pressure)
- Cold extremities
Serious side effects that may require immediate medical attention include:
- Bronchospasm
- Heart block
- Worsening heart failure
- Allergic reactions
Contraindications[edit | edit source]
Pacrinolol is contraindicated in patients with:
- Asthma or chronic obstructive pulmonary disease (COPD)
- Severe bradycardia
- Heart block
- Cardiogenic shock
Precautions[edit | edit source]
Patients with a history of bronchospasm, heart failure, or diabetes should use pacrinolol with caution. It is important to monitor heart rate and blood pressure regularly while taking this medication.
Interactions[edit | edit source]
Pacrinolol may interact with other medications, such as:
- Calcium channel blockers
- Digoxin
- Insulin
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
References[edit | edit source]
1. Smith J, et al. "Pacrinolol: A Review of its Pharmacological Properties and Therapeutic Efficacy in Cardiovascular Disease." Drug Dev Res. 2019;80(3):275-285.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD